05:05 PM EDT, 05/07/2024 (MT Newswires) -- Bio-Rad Laboratories ( BIO/B ) reported Q1 non-GAAP net income Tuesday of $2.29 per diluted share, down from $3.34 a year earlier.

Four analysts polled by Capital IQ expected $2.14 per share.

Revenue for the quarter that ended March 31 was $610.8 million, down from $676.8 million a year ago.

Four analysts surveyed by Capital IQ expected $620.1 million.

For 2024, the company continues to expect non-GAAP, currency-neutral revenue growth of 1% to 2.5%.

Shares of Bio-Rad Laboratories ( BIO/B ) were down 1.4% in after-hours trading.

Price: 276.00, Change: -3.91, Percent Change: -1.40